Rolofylline

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRolofylline
Drug Alias NameRolofyllina罗咯茶碱洛罗茶碱RolofyllinumHMR-4902 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor agonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsHeart FailureRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovacardia IncMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsHeart FailureRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG